Trials / Conditions / Refractory AL Amyloidosis
Refractory AL Amyloidosis
3 registered clinical trials studyying Refractory AL Amyloidosis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory A NCT07081646 | Alexion Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Recruiting | Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Cha NCT04847453 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Pre NCT04270175 | Weill Medical College of Cornell University | Phase 2 |